Completed
Study For Patients With Untreated Gastric Cancer Who Will Receive Capecitabine And Lapatinib
NCT00526669
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +10 more
- Locations
-
- GSK Investigational Site Loma Linda, California, United States
- GSK Investigational Site Los Angeles, California, United States
- GSK Investigational Site Washington D.C., District of Columbia, United States
- GSK Investigational Site Shreveport, Louisiana, United States